Inhibition of Fap Promotes Cardiac Repair by Stabilizing BNP
Yuxi SunMengqiu MaDandan CaoAncheng ZhengYiying ZhangYang SuJianfang WangYanhua XuMi ZhouYansong TangYifan LiuTeng MaAoyuan FanXiaoying ZhangQiaoling ZhuJiachen QinChunyang MoYawei XuLi ZhangDachun XuRui YueInstitute for Regenerative Medicine,Shanghai East Hospital,Frontier Science Center for Stem Cell Research,Shanghai Key Laboratory of Signaling and Disease Research,School of Life Sciences and Technology,Tongji University,China (D.C.,Y.Z.,J.W.,Yanhua Xu,X.Z.,Q.Z.,J.Q.,C.M.,R.Y.).Department of Cardiology,Pan-Vascular Research Institute of Tongji University,Shanghai Tenth People's Hospital,Tongji University School of Medicine,China (Y. Sun,M.M.,Y. Su,Yanhua Xu,Y.T.,Y.L.,T.M.,Yawei Xu,D.X.).Shanghai Institute of Stem Cell Research and Clinical Translation,China (R.Y.).Department of Cardiology and Institute for Developmental and Regenerative Cardiovascular Medicine,Xinhua Hospital,Shanghai Jiao Tong University School of Medicine,China. (Y. Sun,A.Z.,M.Z.,L.Z.)Department of Cardiac Surgery,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,China. (A.F.)
DOI: https://doi.org/10.1161/CIRCRESAHA.122.320781
IF: 23.213
2023-02-10
Circulation Research
Abstract:Circulation Research, Ahead of Print. RATIONALE:Myocardial infarction (MI) elicits cardiac fibroblast activation and ECM (extracellular matrix) deposition to maintain the structural integrity of the heart. Recent studies demonstrate that Fap (fibroblast activation protein)—a prolyl-specific serine protease—is an important marker of activated cardiac fibroblasts after MI.OBJECTIVE:This study aims to test whether Fap is a critical regulator of cardiac repair after MI and to uncover the underlying cellular and molecular mechanisms for better treatment of MI.METHODS AND RESULTS:We found that Fap is upregulated in patient cardiac fibroblasts after cardiac injuries, while plasma Fap is downregulated and functions as a prognostic marker for cardiac repair. Genetic or pharmacological inhibition of Fap in mice significantly improved cardiac function after MI. Histological and transcriptomic analyses showed that Fap inhibition leads to increased angiogenesis in the peri-infarct zone, which promotes ECM deposition and alignment by cardiac fibroblasts and prevents their overactivation, thereby limiting scar expansion. Mechanistically, we found that BNP (brain natriuretic peptide) is a novel substrate of Fap that mediates postischemic angiogenesis. Fap degrades BNP to inhibit vascular endothelial cell migration and tube formation. Pharmacological inhibition of Fap inNppb(encoding pre-proBNP) orNpr1(encoding the BNP receptor)-deficient mice showed no cardioprotective effects, suggesting that BNP is a physiological substrate of Fap.CONCLUSIONS:This study identifies Fap as a negative regulator of cardiac repair and a potential drug target to treat MI. Inhibition of Fap stabilizes BNP to promote angiogenesis and cardiac repair.
cardiac & cardiovascular systems,peripheral vascular disease,hematology